Miles S. Chen, Ph.D. - Publications

2015 Statistics University of California, Los Angeles, Los Angeles, CA 
Personality, drug abuse, psychometrics, structural equation modeling, factor analysis, reliability theory

16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Wang K, Guo WX, Chen MS, Mao YL, Sun BC, Shi J, Zhang YJ, Meng Y, Yang YF, Cong WM, Wu MC, Lau WY, Cheng SQ. Multimodality Treatment for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Large-Scale, Multicenter, Propensity Mathching Score Analysis. Medicine. 95: e3015. PMID 26986115 DOI: 10.1097/MD.0000000000003015  0.36
2016 Xu L, Wang J, Kim Y, Shuang ZY, Zhang YJ, Lao XM, Li YQ, Chen MS, Pawlik TM, Xia JC, Li SP, Lau WY. A randomized controlled trial on patients with or without adjuvant autologous cytokine-induced killer cells after curative resection for hepatocellular carcinoma Oncoimmunology. 5. DOI: 10.1080/2162402X.2015.1083671  0.36
2015 Jiang SS, Tang Y, Zhang YJ, Weng DS, Zhou ZG, Pan K, Pan QZ, Wang QJ, Liu Q, He J, Zhao JJ, Li J, Chen MS, Chang AE, Li Q, et al. A phase I clinical trial utilizing autologous tumor-infiltrating lymphocytes in patients with primary hepatocellular carcinoma. Oncotarget. PMID 26515587 DOI: 10.18632/oncotarget.5463  0.36
2015 Zhou DS, Wang HB, Zhou ZG, Zhang YJ, Zhong Q, Xu L, Huang YH, Yeung SC, Chen MS, Zeng MS. TACC3 promotes stemness and is a potential therapeutic target in hepatocellular carcinoma. Oncotarget. PMID 26219398 DOI: 10.18632/oncotarget.4643  0.36
2015 Xu L, Zhou DS, Zhao J, Spolverato G, Zhang YJ, Li SP, Chen MS, Pawlik TM. Long-term therapy with sorafenib is associated with pancreatic atrophy. The Journal of Surgical Research. PMID 26115806 DOI: 10.1016/j.jss.2015.04.035  0.36
2015 Zhou ZG, Zheng XR, Zhou Q, Shi M, Zhang YJ, Guo RP, Yuan YF, Chen MS, Lin XJ, Lao XM, Li SP. Impact of oral anti-hepatitis B therapy on the survival of patients with hepatocellular carcinoma initially treated with chemoembolization. Chinese Journal of Cancer. 34: 14. PMID 26058595 DOI: 10.1186/s40880-015-0017-7  0.36
2015 Zhou DS, Xu L, Luo YL, He FY, Huang JT, Zhang YJ, Chen MS. Inflammation scores predict survival for hepatitis B virus-related hepatocellular carcinoma patients after transarterial chemoembolization. World Journal of Gastroenterology : Wjg. 21: 5582-90. PMID 25987783 DOI: 10.3748/wjg.v21.i18.5582  0.36
2015 Pan QZ, Wang QJ, Dan JQ, Pan K, Li YQ, Zhang YJ, Zhao JJ, Weng DS, Tang Y, Huang LX, He J, Chen SP, Ke ML, Chen MS, Wicha MS, et al. A nomogram for predicting the benefit of adjuvant cytokine-induced killer cell immunotherapy in patients with hepatocellular carcinoma. Scientific Reports. 5: 9202. PMID 25776856 DOI: 10.1038/srep09202  0.36
2015 Xu L, Peng ZW, Chen MS, Shi M, Zhang YJ, Guo RP, Lin XJ, Lau WY. Prognostic nomogram for patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization. Journal of Hepatology. 63: 122-30. PMID 25725438 DOI: 10.1016/j.jhep.2015.02.034  0.36
2015 Gao HJ, Zhao MC, Zhang YJ, Zhou DS, Xu L, Li GB, Chen MS, Liu J. Monocarboxylate transporter 4 predicts poor prognosis in hepatocellular carcinoma and is associated with cell proliferation and migration. Journal of Cancer Research and Clinical Oncology. 141: 1151-62. PMID 25446815 DOI: 10.1007/s00432-014-1888-8  0.36
2014 Dai QS, Gu HL, Ye S, Zhang YJ, Lin XJ, Lau WY, Peng ZW, Chen MS. Transarterial chemoembolization vs. conservative treatment for unresectable infiltrating hepatocellular carcinoma: A retrospective comparative study. Molecular and Clinical Oncology. 2: 1047-1054. PMID 25279196 DOI: 10.3892/mco.2014.391  0.36
2014 Cai JQ, Cai SW, Cong WM, Chen MS, Chen P, Chen XP, Chen YL, Chen YF, Dai CL, Huang Q, Huang ZY, Jiang B, Jiang B, et al. Diagnosis and treatment of cholangiocarcinoma: a consensus from surgical specialists of China. Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban. 34: 469-75. PMID 25135713 DOI: 10.1007/s11596-014-1301-5  0.36
2014 Sun J, Jin G, Qin MX, Wan ZB, Wang JB, Wang C, Guo WY, Xu L, Ning X, Xu J, Pu XJ, Chen MS, Zhao HM. Detection of acute cerebral hemorrhage in rabbits by magnetic induction. Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas MéDicas E BiolóGicas / Sociedade Brasileira De BiofíSica ... [Et Al.]. 47: 144-50. PMID 24519130 DOI: 10.1590/1414-431X20132978  0.36
2014 Gao HJ, Xu L, Zhang YJ, Chen MS. Long-term survival of patients with hepatocellular carcinoma with inferior vena cava tumor thrombus treated with sorafenib combined with transarterial chemoembolization: report of two cases and literature review. Chinese Journal of Cancer. 33: 259-64. PMID 24325788 DOI: 10.5732/cjc.013.10133  0.36
2013 Peng ZW, Liu FR, Ye S, Xu L, Zhang YJ, Liang HH, Lin XJ, Lau WY, Chen MS. Radiofrequency ablation versus open hepatic resection for elderly patients (> 65 years) with very early or early hepatocellular carcinoma. Cancer. 119: 3812-20. PMID 23922119 DOI: 10.1002/cncr.28293  0.36
2013 Pan K, Li YQ, Wang W, Xu L, Zhang YJ, Zheng HX, Zhao JJ, Qiu HJ, Weng DS, Li JJ, Wang QJ, Huang LX, He J, Chen SP, Ke ML, ... ... Chen MS, et al. The efficacy of cytokine-induced killer cell infusion as an adjuvant therapy for postoperative hepatocellular carcinoma patients. Annals of Surgical Oncology. 20: 4305-11. PMID 23892527 DOI: 10.1245/s10434-013-3144-x  0.36
Show low-probability matches.